Observational studyJournal of global health2025
Evaluating the burden of respiratory tract infections among mortality cases in Karachi, Pakistan: a post-pandemic surveillance analysis.
Observational study in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genomic characterization of an ESBL-producingMicrobiology spectrum · 2026Article
- Morbidity patterns, mortality, and antimicrobial resistance among children hospitalized in neonatal and pediatric intensive care units in a rural area of Vietnam.IJID regions · 2026Article
- Outcomes of Noninvasive Positive Pressure Ventilation via RAM Cannula in Pediatric Intensive Care: A Preliminary Report.International journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Respiratory tract infections (RTIs) significantly impact global health, but particularly affect low- and middle-income countries. They contribute to morbidity and mortality, especially among vulnerable populations. We evaluated the burden of RTIs in mortality cases in an urban slum of Karachi, Pakistan, during the post-COVID-19 pandemic period. Methods: We conducted a prospective observational study from September 2022 to October 2023 in Ali Akbar Shah, Karachi. We collected 350 nasal swabs from deceased individuals and tested them for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory pathogens using reverse transcription polymerase chain reaction (RT-PCR) and the TaqMan Array Card (TAC) assay. Additionally, we performed verbal autopsies to determine the cause of death. Results: Most deaths occurred at home (n/N = 234/350, 66.8%). Hospital-based deaths were more common among children under five years of age (n/N = 81/132, 61.3%), while individuals over five were more likely to die at home (n/N = 180/211, 85.3%). In the post-pandemic period, 6% (n/N = 21/350) of deceased individuals tested positive for COVID-19. The TAC assay analysis found Klebsiella pneumoniae (n/N = 150/350, 42.8%), Staphylococcus aureus (n/N = 141/350, 40.3%), and Streptococcus pneumoniae (n/N = 106/350, 30.3%) to be the most common pathogens. Co-infections were common, with 90.4% of COVID-19-positive cases also harbouring other respiratory pathogens. Conclusions: We observed a high burden of RTIs in Karachi, with Klebsiella pneumoniae playing a major role in overall mortality across all age groups. Co-infections with multiple respiratory pathogens were common, underscoring the need for better diagnostic and treatment strategies. Improved surveillance and potential vaccine development for Klebsiella pneumoniae and other notable pathogens could reduce mortality in similar settings. However, limitations such as post-mortem colonisation, contamination, and the absence of histopathologic confirmation necessitate cautious interpretation of pathogen-related mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.